NIAID Prioritizes Development Of Universal Influenza Vaccine

United Press International: NIH agency’s priority: Developing universal flu vaccine
“The National Institute of Allergy and Infectious Diseases has announced a new priority: developing a universal influenza vaccine that can protect people of all ages against multiple flu strains. The NIAID, which is part of the National Institutes of Health, on Wednesday detailed a new strategic plan for addressing the research areas essential to creating a safe and effective universal influenza vaccine. The agency also published a paper Wednesday in the Journal of Infectious Disease…” (Cone, 2/28).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.